A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Avermectin B1a | CAS 65195-55-3 - Request Quote

Picture of Avermectin B1a

Avermectin B1a

SZ CAT No:SZ-A038002
CAS No
65195-55-3
Mol.F.
C48H72O14
Mol.Wt.
873.1
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Avermectin B1a is chemically 5-O-Demethylavermectin A1a (> 95% ; Avermectin B1a (> 95%). Avermectin B1a is supplied with detailed characterization data compliant with regulatory guideline. Avermectin B1a can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pharmaceutical Reference Standards.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 65195-55-3

Purchase 65195-55-3

Order 65195-55-3

Enquire 65195-55-3

price of 65195-55-3

65195-55-3 Supplier

65195-55-3 Manufacturer

65195-55-3 Exporter

buy high quality Avermectin B1a

Purchase Avermectin B1a

Avermectin B1a suppliers

Avermectin B1a manufacturers

Avermectin B1a price

Order Avermectin B1a

Enquire Avermectin B1a

Avermectin B1a cost

Avermectin B1a Supplier

Avermectin B1a Distributor

Avermectin B1a for Method Validation

Pharmaceutical Reference Standards Reference Standard

Avermectin B1a for ANDA Filing

Avermectin B1a for Forced Degradation Studies

Avermectin B1a Identification Standards

Avermectin B1a for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,